Head to Head Survey: SUIC Worldwide (OTCMKTS:SUIC) and Firefly Neuroscience (NASDAQ:AIFF)

Firefly Neuroscience (NASDAQ:AIFFGet Free Report) and SUIC Worldwide (OTCMKTS:SUICGet Free Report) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares Firefly Neuroscience and SUIC Worldwide”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Firefly Neuroscience $110,000.00 239.15 -$10.46 million ($2.09) -0.89
SUIC Worldwide $150,000.00 29.23 -$230,000.00 N/A N/A

SUIC Worldwide has higher revenue and earnings than Firefly Neuroscience.

Volatility and Risk

Firefly Neuroscience has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Comparatively, SUIC Worldwide has a beta of 38.38, suggesting that its share price is 3,738% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Firefly Neuroscience and SUIC Worldwide, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Firefly Neuroscience 1 0 0 0 1.00
SUIC Worldwide 0 0 0 0 0.00

Profitability

This table compares Firefly Neuroscience and SUIC Worldwide’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Firefly Neuroscience -2,705.88% -319.00% -191.27%
SUIC Worldwide N/A N/A -634.96%

Institutional & Insider Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 65.8% of SUIC Worldwide shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

SUIC Worldwide beats Firefly Neuroscience on 6 of the 10 factors compared between the two stocks.

About Firefly Neuroscience

(Get Free Report)

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About SUIC Worldwide

(Get Free Report)

Suic Worldwide Holdings Ltd is venture capital firm specializing in growth capital investments. The firm seeks to invest in private enterprises and the public sector that develop products and services adopting core capabilities of the IoT, big data, AI, fintech and blockchain. The firm provides IT management consulting services. Suic Worldwide Holdings Ltd was formerly known as Sino United Worldwide Consolidated Ltd. Suic Worldwide Holdings Ltd was incorporated in 2006 and is headquartered in Flushing, New York.

Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.